CA2631838A1 - Use of anecortave acetate as an adjunct during filtration bleb surgery - Google Patents

Use of anecortave acetate as an adjunct during filtration bleb surgery Download PDF

Info

Publication number
CA2631838A1
CA2631838A1 CA002631838A CA2631838A CA2631838A1 CA 2631838 A1 CA2631838 A1 CA 2631838A1 CA 002631838 A CA002631838 A CA 002631838A CA 2631838 A CA2631838 A CA 2631838A CA 2631838 A1 CA2631838 A1 CA 2631838A1
Authority
CA
Canada
Prior art keywords
administration
surgery
iop
glaucoma
angiostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002631838A
Other languages
English (en)
French (fr)
Inventor
Alan L. Robin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon, Inc.
Alan L. Robin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc., Alan L. Robin filed Critical Alcon, Inc.
Publication of CA2631838A1 publication Critical patent/CA2631838A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
CA002631838A 2005-12-23 2006-12-22 Use of anecortave acetate as an adjunct during filtration bleb surgery Abandoned CA2631838A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75351105P 2005-12-23 2005-12-23
US60/753,511 2005-12-23
PCT/US2006/062541 WO2007076467A2 (en) 2005-12-23 2006-12-22 Use of anecortave acetate as an adjunct during filtration bleb surgery

Publications (1)

Publication Number Publication Date
CA2631838A1 true CA2631838A1 (en) 2007-07-05

Family

ID=38067101

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002631838A Abandoned CA2631838A1 (en) 2005-12-23 2006-12-22 Use of anecortave acetate as an adjunct during filtration bleb surgery

Country Status (9)

Country Link
EP (1) EP1962857A2 (ja)
JP (1) JP2009521511A (ja)
KR (1) KR20080078042A (ja)
CN (1) CN101346145A (ja)
AU (1) AU2006330531A1 (ja)
BR (1) BRPI0620411A2 (ja)
CA (1) CA2631838A1 (ja)
WO (1) WO2007076467A2 (ja)
ZA (1) ZA200805052B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080125406A1 (en) * 2005-10-14 2008-05-29 Robin Alan L Method for Treating Primary and Secondary Forms of Glaucoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798356A (en) * 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
AU1970197A (en) * 1996-05-09 1997-11-26 Alcon Laboratories, Inc. Use of steroid compounds to prevent non-cancerous tissue growth
US6011023A (en) * 1997-08-27 2000-01-04 Alcon Laboratories, Inc. Angiostatic steroids
US6489305B1 (en) * 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
US20050239760A1 (en) * 2004-04-23 2005-10-27 Alcon, Inc. Angiostatic agents and methods and compositions for controlling ocular hypertension

Also Published As

Publication number Publication date
AU2006330531A1 (en) 2007-07-05
EP1962857A2 (en) 2008-09-03
CN101346145A (zh) 2009-01-14
JP2009521511A (ja) 2009-06-04
WO2007076467A2 (en) 2007-07-05
BRPI0620411A2 (pt) 2011-11-08
KR20080078042A (ko) 2008-08-26
ZA200805052B (en) 2009-10-28
WO2007076467A3 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
US20070197491A1 (en) Method for treating primary and secondary forms of glaucoma
EP1755616B1 (en) Treatment of exudative retinopathy with mineralcorticoids
Jonas Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases
US20080125406A1 (en) Method for Treating Primary and Secondary Forms of Glaucoma
Grzybowski et al. The role of steroids and NSAIDs in prevention and treatment of postsurgical cystoid macular edema
Kaufman et al. Cataract extraction in patients with pars planitis
JP2007056041A (ja) 病的な眼の新脈管形成を処置するための糖質コルチコイド処方物
Grzybowski et al. Dexamethasone intraocular suspension: a long-acting therapeutic for treating inflammation associated with cataract surgery
CA2631838A1 (en) Use of anecortave acetate as an adjunct during filtration bleb surgery
US20070043006A1 (en) Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
JP2007500250A5 (ja)
MX2008007884A (en) Use of anecortave acetate as an adjunct during filtration bleb surgery
Agahan et al. Intracameral Triamcinolone for the Treatment of Hyphema and Post-Surgical Iridocyclitis
US20040097478A1 (en) Remedies for retina and choroid diseases containing steroids as the active ingredient
Aswin Outcome of glaucoma surgery in patients on prostaglandin analogues
CN101365456A (zh) 治疗原发性和继发性形式的青光眼的方法
Mavrikakis et al. Current trends of intravitreal steroid use in retinal diseases
Herndon Medication-related Ocular Surface Disorders Among Glaucoma Patients
ZA200509532B (en) Formulations or non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
AU2005232693A1 (en) Treatment of ophthalmic conditions with mineralcorticoids

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20121224